Breaking Down Rengo Co., Ltd. Financial Health: Key Insights for Investors

Curious whether Rengo Co., Ltd. (3941.T) is a value play or a cautionary tale? The company posted robust top-line momentum with net sales of ¥993,251 million in FY2025-a 10.3% year-on-year rise (and a FY2025 revenue growth of 10.26% versus 6.47% in FY2024) and TTM revenue of ¥995.34 billion-yet profitability shows strain: operating income fell to ¥37,408 million (down 23.4%), ordinary income slid 18.4% to ¥39,178 million, and net profit attributable to owners dropped 12.3% to ¥28,979 million, compressing operating, ordinary and net margins to 3.77%, 3.94% and 2.92% respectively; liquidity flags include a 31.49% decline in cash and cash equivalents to ¥70,551 million, while valuation metrics point to a market capitalization of ¥276.82 billion and a P/S ratio of 0.28, and growth levers-analysts' forecasted revenue of ¥1.04 trillion in 2026, the addition of 15 subsidiaries (offset by 6 exclusions), and revenue-per-employee of about ¥39.80 million across 25,011 staff-sit alongside downside risks such as a 41.6% fall in attributable profit in H1 2025 and a 23.1% downward revision to the ordinary profit forecast, so dig into the full analysis to weigh Rengo's resilience, valuation and path forward.

Rengo Co., Ltd. (3941.T) - Revenue Analysis

• FY 2025 net sales: ¥993,251 million (↑10.3% vs prior year)
• FY 2025 growth rate (reported): 10.26% vs FY2024 (6.47%)
• Trailing twelve months (TTM) revenue as of Sep 30, 2025: ¥995.34 billion (↑5.54% YoY)
• Q1-Q3 quarter (ending Sep 30, 2025) revenue: ¥247.82 billion (↓1.12% YoY for that quarter)
• Revenue per employee: ≈ ¥39.80 million (25,011 employees)
• Market capitalization: ¥276.82 billion

Rengo Co., Ltd. (3941.T) - Profitability Metrics

• Operating income fell to ¥37,408 million in FY 2025, a 23.4% decline from FY 2024, signaling weaker core operations or higher operating costs.
• Ordinary income decreased 18.4% to ¥39,178 million, indicating pressures beyond purely operating lines (e.g., financial or non-operating items).
• Net profit attributable to owners was ¥28,979 million, down 12.3%, showing some resilience versus operating decline but still a material contraction.
• Margins compressed across the board: operating margin dropped to 3.77% (from 5.43%), ordinary margin to 3.94% (from 5.32%), and net margin to 2.92% (from 3.67%).
• Margin deterioration (operating: -1.66 pp; ordinary: -1.38 pp; net: -0.75 pp) suggests cost pressure and/or pricing challenges affecting profitability stability.

Rengo Co., Ltd. (3941.T) - Debt vs. Equity Structure

• Net assets (Mar 31, 2025): ¥500,244 million (up from ¥438,978 million the prior year).
• Reported disclosures do not specify total liabilities to net assets ratio.
• Debt-to-equity ratio is not provided in available sources.
• No detailed breakdown of long-term debt obligations has been disclosed.
• Observed balance-sheet movement implies an equity-heavy capital structure with limited public detail on leverage.
• The lack of explicit debt figures suggests a conservative approach to leveraging, or limited external borrowing disclosure.

Rengo Co., Ltd. (3941.T) Liquidity and Solvency

Rengo Co., Ltd.'s most directly reported liquidity figure for the fiscal year ending March 31, 2025 shows a notable decline in cash reserves, with several key solvency metrics not disclosed, complicating a full assessment of short- and long-term financial stability.

• Cash and cash equivalents decreased by 31.49% to ¥70,551 million as of March 31, 2025.
• Current ratio (current assets / current liabilities): not specified in the available data.
• Quick ratio: not provided in the available sources.
• Cash flow from operations for FY ending March 31, 2025: not disclosed.
• The decline in cash reserves may constrain short-term liquidity and flexibility for capital expenditures, debt service, or opportunistic investments.
• The absence of detailed solvency ratios (e.g., debt-to-equity, interest coverage) limits ability to evaluate long-term leverage and default risk.

• Investors should monitor subsequent interim reports or disclosures for: robust cash-flow statements, balance-sheet breakdowns enabling current/quick ratio calculations, and explicit solvency metrics.
• For additional context on shareholders and ownership dynamics that may affect capital decisions, see: Exploring Rengo Co., Ltd. Investor Profile: Who's Buying and Why?

Rengo Co., Ltd. (3941.T) - Valuation Analysis

• Market capitalization: ¥276.82 billion (as of December 1, 2025)
• Stock price: ¥1,116 (as of December 1, 2025)
• Trailing twelve months (TTM) revenue: ¥995.34 billion
• Price-to-Sales (P/S) ratio: 0.28
• Price-to-Earnings (P/E) ratio: not available in the provided data

• A P/S of 0.28 places Rengo among low P/S valuations, implying the market values the company at less than one-third of its annual sales.
• The lack of earnings (net income) detail prevents calculation of a reliable P/E ratio and hinders profitability-based valuation.
• Low P/S can signal potential undervaluation, but requires cross-checking with margins, cash flow, balance sheet strength, and industry comparables.
• Investors should examine segment profitability, recent trends in operating income, and non-operating items before inferring intrinsic value.

Rengo Co., Ltd. (3941.T) - Risk Factors

Key risk indicators for Rengo Co., Ltd. (3941.T) drawn from recent reporting and performance metrics highlight material near‑term and structural risks that investors should weigh.

• Profitability shock: Profit attributable to owners of the parent declined by 41.6% in the six months ending September 30, 2025.
• Earnings forecast cut: Ordinary profit forecast for the fiscal year ending March 31, 2025 was revised downward by 23.1%.
• Margin compression: Operating profit margin deteriorated from 2.9% to 1.6% in Q4 year‑over‑year.
• Liquidity reduction: Cash and cash equivalents decreased by 31.49%, elevating short‑term funding risk.
• Sector concentration: Heavy reliance on the packaging industry exposes the company to demand cyclicality and raw material price volatility.
• Disclosure gap: Limited publicly available detail on debt structure impedes assessment of leverage and refinancing risk.

Observed and potential impacts for investors:

• Cash strain could force reliance on bank borrowing or asset sales if operational cash flow does not recover.
• Worsening margins suggest limited pricing power or rising input costs; sustained pressure may compress free cash flow.
• Sector concentration increases correlation with packaging demand cycles-slumps in FMCG, e‑commerce, or industrial activity could materially affect revenue.
• Without granular debt data (maturities, covenants, interest rates), tail‑risk from refinancing needs or covenant breaches cannot be ruled out.
• Analysts and investors should monitor quarterly cash flow, inventory levels, raw material cost trends, and any management commentary on deleveraging or capital raises.

Additional context and Rengo's stated strategic orientation can be reviewed here: Mission Statement, Vision, & Core Values (2026) of Rengo Co., Ltd.

Rengo Co., Ltd. (3941.T) - Growth Opportunities

• Revenue growth: FY2025 grew 10.26% versus FY2024, which itself rose 6.47% year-over-year.
• Subsidiary optimization: 15 new companies added and 6 excluded during the latest restructuring (net +9), indicating active operational and portfolio management.
• Analyst outlook: consensus forecasts a 9.6% revenue increase to ¥1.04 trillion in FY2026, signaling continued momentum.
• Valuation indicator: a low price-to-sales (P/S) ratio of 0.28, suggesting possible undervaluation relative to peers.
• Leverage posture: absence of detailed debt disclosures implies a conservative approach to borrowing, leaving room for strategic, low-risk expansion.
• Market focus: deliberate efforts to broaden domestic market share while accelerating international expansion initiatives.

• Key growth levers: capacity expansion in strategic regions, cross-selling across newly consolidated subsidiaries, and potential M&A funded by conservative leverage.
• Investor considerations: the combination of steady revenue acceleration, low P/S, and a light-debt posture may present an attractive risk/reward profile for growth-oriented investors.